SecBot SecBot
8-K ·Filed Aug 19, 2026

NRXS

Neuraxis, INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001493152-26-039247
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

This filing is routine compensation administration with no new operational or financial information. Monitor the next quarterly filing for any changes in share count or cash burn rate.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
NRXS ▲ +21.37% at T+20d
NEUTRAL call +21.37% · α vs SPY +21.37% · entry $6.27 → $7.61
Next anchor: T+60d in 16d
Latest observation: T+45 +44.89% FF3 residual α
Entry = T+0 close
Aug 19, 2026
via day close
T+1d
-1.91%
call -1.91% · α -2.32%
$6.15
settled 2mo ago
T+5d
-3.99%
call -3.99% · α -5.10%
$6.02
settled 2mo ago
T+20d
+21.37%
call +21.37% · α +21.37%
$7.61
settled 6w ago
T+60d
Pending
in 16d

Price Chart

Loading chart...

Executive Summary

Neuraxis filed an 8-K detailing the effectiveness of a stock option exchange on July 24, 2026, where 1,319,394 outstanding options were cancelled and replaced with immediately-vesting RSUs. Separately, on August 13, 2026, the company granted new time-vesting RSUs to officers and a one-time equity award of 127,120 shares to independent directors to address below-market compensation. These are routine compensatory arrangements with no material financial impact disclosed, making the filing neutral.

Key Facts

  • Stock option exchange went effective on July 24, 2026, cancelling 1,319,394 options and issuing an equivalent number of immediately-vesting RSUs.
  • CEO Brian Carrico received 199,188 immediately-vesting RSUs from the exchange; CMO Adrian Miranda received 199,106; CRO Thomas Carrico received 193,678.
  • On August 13, 2026, the company granted 193,329 RSUs to Brian Carrico, 141,479 to CFO Timothy Henrichs, 133,341 to Adrian Miranda, and 135,906 to Thomas Carrico, vesting over three years.
  • Independent directors received a one-time grant of 127,120 shares of common stock to address historical compensation below market levels.

Financial Impact

No financial figures disclosed; the filing describes equity compensation arrangements with no dollar amounts.

dilution

Risk Factors

  • Potential dilution from RSU vesting, though amounts are small relative to market cap.
  • No material risk identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-039247
Document: 0001493152-26-039247-index-headers.html0001493152-26-039247
Document: 0001493152-26-039247-index.html0001493152-26-039247
Document: 0001493152-26-039247.txt0001493152-26-039247
14 reports for NRXS
Performance horizon
50% Hit rate @ T+20 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +17.12%Aug 4, 2026
Filters
Rows
Reports for NRXS — sortable, filterable
TypeNow
Oct 14, 2026
13d ago
8-K
NEUTRAL ★ 2/10
$7.74awaiting T+20—$7.36 (−4.91%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$6.27 $7.61▲ +21.37%▲ +21.37%$7.36 (+17.38%)
Aug 11, 2026
11w ago
Press Release
MIXED ★ 5/10
$6.35 $5.73▼ −9.76%▼ −8.70%$7.36 (+15.91%)
Aug 4, 2026
12w ago
EFFECT
BEARISH ★ 6/10
$7.01 $5.81▲ +17.12%▲ +15.88%$7.36 (−4.99%)
Jul 30, 2026
12w ago
S-3/A
BEARISH ★ 6/10
$6.28 $6.02▲ +4.14%▲ +8.11%$7.36 (−17.20%)
Jul 10, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$7.14 $7.09▼ −0.70%▼ −3.13%$7.36 (+3.08%)
May 12, 2026
24w ago
Press Release
BULLISH ★ 7/10
$8.27 $6.80▼ −17.78%▼ −16.05%$7.36 (−11.00%)
May 5, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$8.69 $7.01▼ −19.33%▼ −24.29%$7.36 (−15.30%)
Apr 28, 2026
26w ago
DEFA14A
NEUTRAL ★ 4/10
$7.44 $7.29▼ −2.02%▼ −8.06%$7.36 (−1.08%)
Apr 21, 2026
27w ago
8-K
BULLISH ★ 7/10
$7.51 $7.25▼ −3.46%▼ −6.63%$7.36 (−2.00%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (15h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026